Search results for: “oncology”
-
Theradiag launches €5.3 million rights issue
•
PARIS, FRANCE: Theradiag, a company specializing in in vitro diagnostics and Theranostics, announced the launch of a rights…
-
Medivir AB appoints Jens Lindberg as CEO
•
STOCKHOLM, SWEDEN: Medivir AB announced the Board of Directors has appointed Jens Lindberg as CEO of the company.…
-
Ipsen appoints Mari Scheiffele as EVP and President, Specialty Care International
•
PARIS, FRANCE: Ipsen announced the appointment of Mari Scheiffele as EVP and President, Specialty Care International, effective November…
-
Exscientia IPO priced at $304.7mn, notifies $160mn placements
•
LONDON, UK: Frontier IP’s portfolio company Exscientia plc has announced today the pricing of its initial public offering…
-
AstraZeneca to fully acquire Caelum Biosciences
•
LONDON, UK: AstraZeneca‘s Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences for CAEL-101,…
-
Physiomics hires Hayley Close as Head of Business Development
•
LONDON, UK: Physiomics plc, the consultancy using mathematical models to support the development of drug treatment regimens and…
-
Jennifer Chow appointed CEO & MD of Chimeric Therapeutics
•
SYDNEY, AUSTRALIA: Chimeric Therapeutics announced the appointment of current Chief Operating Officer, Jennifer Chow, as Chief Executive Officer…
-
HUTCHMED selected for certain Hang Seng Indexes
•
HONG KONG: HUTCHMED (China) Limited announced that HUTCHMED has been selected as a constituent stock of several indexes…
-
Venture Life Group acquires brands and assets from Helsinn Healthcare
•
LONDON, UK: Venture Life Group has acquired a series of oncology support product assets from Helsinn Healthcare SA…
-
Abcam to acquire BioVision for $340 million
•
CAMBRIDGE, UK: Abcam plc, a global leader in the supply of life science research tools, has entered into…
-
AstraZeneca complete acquisition of Alexion Pharmaceuticals
•
LONDON, UK: AstraZeneca today completed the acquisition of Alexion Pharmaceuticals Inc. The closing of the acquisition marks the…
-
Imfinzi approved in China for extensive-stage SCLC
•
LONDON, UK: AstraZeneca‘s Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with extensive-stage small…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.